Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M207407200 on September 6, 2002

J. Biol. Chem., Vol. 277, Issue 46, 44285-44291, November 15, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/46/44285    most recent
M207407200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, J.
Right arrow Articles by Andersen, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, J.
Right arrow Articles by Andersen, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of Caspases Protects Cerebellar Granule Cells of the Weaver Mouse from Apoptosis and Improves Behavioral Phenotype*

Jun PengDagger , Zhijin Wu§, Yongqin WuDagger , Mike Hsu§, Fang Feng StevensonDagger , Rapee Boonplueang§, Suzanne K. Roffler-Tarlov, and Julie K. AndersenDagger §||

From the Dagger  Buck Institute for Age Research, Novato, California 94945, § Program in Molecular Biology, Department of Biological Sciences, University of Southern California, Los Angeles, California 90089, and the  Departments of Neuroscience and Anatomy and Cell Biology, Tufts University School of Medicine, Boston, Massachusetts 02111

Received for publication, July 23, 2002, and in revised form, September 4, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The homozygous mouse mutant weaver exhibits a massive loss of cerebellar granule neurons postnatally. The death of these cells is associated with a single amino acid mutation in the G protein-activated inwardly rectifying potassium channel, Girk2. Evidence suggests that both the mutated Girk2 channel and the calcium channel-associated N-methyl-D-aspartate receptor play important roles in the apoptotic death of weaver cerebellar granule cells, but the downstream events associated with this process are unknown. In this study, we demonstrate that the consequences of the mutation result in caspase activation. In addition, our results show that caspase inhibition in vivo decreases caspase activation and granule cell apoptosis and significantly improves behavioral deficits associated with the weaver's phenotype.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The homozygous murine mutant weaver (gene symbol wv) is characterized by ataxia, hyperactivity, and tremor (for a review, see Ref. 1). These neurological defects are associated with the large scale death of neurons in the cerebellum and midbrain during the first month of postnatal development. Homozygous weaver mice exhibit death of cerebellar granule cells (2-4), dopaminergic neurons in the substantia nigra (5-9), Purkinje cells in the cerebellum (10-12), and neurons in the deep cerebellar nuclei (13). The wv defect has been identified as a point mutation in the G protein-activated inwardly rectifying potassium channel gene, Girk2 (14). Girk channels are activated by direct interaction with G proteins (15) and play an important role in controlling cell membrane excitability by maintaining the potassium equilibrium potential (16). It has been observed that the weaver's cerebellar granule cells die by an apoptotic mechanism (17-19). However, the precise nature of the process underlying granule cell death is unclear.

Neuronal apoptosis often involves a family of proteases known as caspases. Caspases are synthesized as precursors that are activated after cleavage. Three categories of caspases have been characterized by the specificity of their substrate cleavage site: caspases generating mature proinflammatory cytokines (caspase-1, -4, and -5) and caspases that traditionally act as either initiators (caspase-6, -8, and -9) or downstream (caspase-2, -3, and -7) as executioners in the apoptotic pathway (20, 21). During development, cell death is essential for regulation of neuronal cell numbers as well as for protection against the propagation of aberrant cells (22). The evidence suggests that caspase-3 participates in neuronal cell death during development (23), after traumatic neuronal injury (24), and ischemia (25), suggesting that caspase-3 may play a critical role in the terminal stage of the apoptotic pathway in neurons.

Death of granule cells caused by the Girk2wv mutation can be rescued, at least for a time, both in vivo and in vitro by elimination of the NR1 subunit of the calcium channel-associated N-methyl-D-aspartate receptor, suggesting that this receptor may also be involved in cerebellar granule cell death (19). The studies reported here were carried out to attempt to determine the downstream events in the death of granule cells that carry two copies of the faulty GIRK2 channel gene. Here we supply direct evidence for the involvement of caspases in the death of the weaver's granule cells. Furthermore, we demonstrate that caspase inhibition attenuates apoptosis in the weaver's granule cells both in vitro and in vivo and also significantly attenuates behavioral deficits associated with this genetic lesion.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- (+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine maleate (MK-801),1 QX-314, verapamil, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma. PCR reagents, DNA polymerase, and the digoxigenin DNA labeling and detection kit were from Roche Molecular Biochemicals. Rabbit polyclonal cleaved caspase-8 antibody was purchased from Smith-Kline Beecham Pharmaceuticals (King of Prussia, PA). Rabbit polyclonal cleaved caspase-9 and rabbit polyclonal cleaved caspase-3 antibodies were from New England Biolabs (Beverly, MA). Z-DEVD-FMK (caspase-3 inhibitor), Z-IETD-FMK (caspase-8 inhibitor), and Z-LEHD-FMK (caspase-9 inhibitor) were purchased from BD Biosciences (San Diego, CA). Anti-TAG-1 (4D7) antibody was from the Developmental Hybridoma Studies Bank, University of Iowa (Iowa City, IA). The FluorAceTM apopain assay kit and caspase substrates were purchased from Bio-Rad.

Animals-- Weaver heterozygous mating pairs (B6CBACa-Aw-J/A-Kcnj6wv) were purchased from the Jackson Laboratory (Bar Harbor, ME). Generation of homozygous p35 transgenic mice has been described elsewhere (26). All animals used in this study were generated from matings between female wv/+, p35 +/- or wv/wv, p35 +/- mice and male wv/+, p35 +/- mice. They were maintained in the vivarium on a 12-h (light/dark) cycle at 22 °C. All procedures were approved by the Institute Animal Care and Use Committee at the Buck Institute.

Determination of Genotype-- Genomic tail DNA was isolated using a kit (Qiagen). wv genotypes were determined by a PCR protocol. This protocol uses a common reverse primer (5'-CAC GGA CTG GAT TAA GAG GAG AAT AAT-3') in combination with a wild-type sequence forward primer (5'-GAG ACA GAA ACC ACC ATC G-3') or a wv sequence forward primer containing the point mutation at the 3'-end (5'-GAG ACA GAA ACC ACC ATC A-3'). PCRs were performed in a total volume of 25 µl and included an initial denaturation at 94 °C/5 min followed by 30 cycles each consisting of denaturation at 94 °C/30 s, annealing at 47 °C/45 s, and extension at 72 °C/60 s, and a final extension of 10 min at 72 °C. Subsequent PCR products were subjected to electrophoresis, and the bands were visualized with ethidium bromide. Each genomic DNA sample was tested with both pairs of primers. Wild-type (+/+) DNA yielded an 87-bp band with wild-type primers but not with wv primers and vice versa for homozygous (wv/wv) DNA. Heterozygous (wv/+) DNA yielded bands with both primer pairs. p35-positive genotypes were identified by slot blot analysis of genomic DNA prepared from tails as described previously (26). Briefly, 5 µg of total DNA was slotted onto positively charged membranes and UV-cross-linked, membranes were hybridized with digoxigenin-labeled RNA probes transcribed from p35 cDNA, and DNA was detected by chemiluminescence.

Preparation of Cerebellar Granular Cells-- Primary cerebellar granule cultures were isolated from 5-7-day-old pups as described previously (27). Cells were seeded onto tissue culture plates coated with poly-D-lysine (Sigma) and BIOCOATTM culture slides (Becton Dickinson) in minimum essential medium (Invitrogen) supplemented with 10% fetal calf serum, 33 mM glucose, 2 mM glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, and 20 mM supplementary KCl.

Immunocytochemistry-- Cultured cerebellar granule cells were fixed with 4% paraformaldehyde, washed in phosphate-buffered saline, and then incubated in phosphate-buffered saline containing 10% normal goat serum and 0.3% Triton-X for 1 h at room temperature. The cells were then incubated with primary antibodies (caspase-9, 1:100; caspase-8, 1:500; caspase-3, 1:50 and TAG-1, 1:50) in blocking solution overnight at 4 °C. The cells were washed with phosphate-buffered saline and incubated with fluorochrome-conjugated secondary antibodies (1:200; Molecular Probes, Inc., Eugene, OR) for 1 h at room temperature. Nuclei were counterstained with 4',6-diamidino-2-phenylindole (Vector). Control experiments were performed in which one or the other of the primary antisera was omitted. No staining was observed under these conditions.

Caspase Activity Assay-- The enzymatic activity of individual caspases was determined using kits from Bio-Rad. Cells were harvested in a buffer (10 mM HEPES, pH 7.4, 2.0 mM EDTA, 0.1% CHAPS, 5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml pepstatin A, 10 µg/ml aprotinin, and 20 µg/ml leupeptin) and then vortexed gently and freeze-thawed four to five times. Lysates were centrifuged at 13,000 × g for 30 min at 4 °C, and the supernatants were collected (26). Total protein extracts were measured using a protein assay kit (Bio-Rad). Supernatant aliquots were incubated with the synthetic substrates Ac-DEVD-AFC (for caspase-3), Ac-LETD-AFC (for caspase-8), and Ac-LEHD-AFC (for caspase-9) for 2 h at 37 °C. Fluorescence was measured at an excitation of 400 nm and an emission of 530 nm using a microplate spectrofluorometer. Serial dilutions of AFC were used as standards. Substrates and inhibitors were used at dosages reported to be optimal for specific caspase selectivity.

Cell Viability by MTT Assay-- MTT tetrazolium salt (5 mg/ml) was added to cells grown in 96-well plates and incubated for 2 h at 37 °C. After crystals were dissolved, absorbance at 540 nm was measured using microplate spectrophotometry. Cell viability at days 2 and 3 was calculated as the amount of MTT dye conversion relative to that of cells at day 1.

Histology-- Postnatal day 7 and 21 pups were anesthetized with Nembutal and transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer. Brains were removed and immersion-fixed in the same fixative overnight at room temperature. Brains were dehydrated in graded ethanols, cleared in xylene, and paraffin-embedded (18). 10-µm-thick serial sagittal sections were cut and mounted on glass slides, which were dried overnight at 42 °C. Sections were deparaffinized, rehydrated through a graded series of ethanols, and washed in water. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeled (TUNEL) staining was performed using an in situ cell death detection kit (Roche Molecular Biochemicals). Subsequently, the sections were counterstained with hematoxylin. In all cases, sections examined were those near the vermis of the cerebellum. Granule cell counts were performed as previously described (17).

For immunohistochemical analysis of cleaved caspase-3, sections were washed in Tris-buffered saline and blocked in Tris-buffered saline containing 0.1% Triton X-100, 1% bovine serum albumin, and 5% normal goat serum for 30 min at room temperature. Sections were incubated with a 1:1000 dilution of primary antibody overnight at 4 °C and washed in Tris-buffered saline. Sections were incubated with a 1:1000 dilution of Cy3-conjugated secondary antibody (Jackson ImmunoResearch).

Behavioral Testing-- Spontaneous locomotor activity, rest time, and climbing ability were measured in an automated Tru Scan® photobeam activity system (Coulbourn Instruments, Allentown, PA) under illumination. Animals were habituated to the apparatus for 15 min prior to running the experiment. Behavioral data were collected in the apparatus over a 10-min period and then analyzed using Tru Scan 99 software (Coulbourn Instruments, Allentown, PA). Depth of holes for climbing experiments was 23 mm deep at a diameter of 22 mm. Rest times were considered any period of 2 s or longer of inactivity.

Statistical Analysis-- Results shown represent the mean ± S.E. for the number (n) of independent experiments performed. Statistical analysis of the data was performed using an analysis of variance software package (Statview).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Involvement of Caspases in Weaver Cerebellar Granule Cell Death-- Apoptosis is initiated by activation of specific proteases of the caspase family (21). To determine whether the major initiator caspase-8 and/or -9 or the executioner caspase, caspase-3, are involved in weaver granule cell death and to delineate their sequence of activation, proteolytic activities associated with these caspases were measured by immunocytochemistry and enzymatic assays. Cerebellar granule cells were purified from postnatal day 5 (P5) homozygous (wv/wv) and wild-type (+/+) mice and cultured for different times before assessing the processing of cleaved caspase-9, -8, and -3 via immunocytochemistry. Caspase-9 induction as monitored by immunofluorescence in wv/wv granule cells occurred first at 18 h, followed by caspase-3 induction at 24 h, which in turn preceded caspase-8 induction at 36 h. In cultures from wv/wv mice, activated caspase-8 and -9 were demonstrated to be primarily in the cytoplasm, whereas caspase-3 showed both nuclear and cytoplasmic localization (Fig. 1A). Negligible caspase-positive activity was noted in +/+ cultures.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Caspase involvement in wv/wv granule cell death. P5 cerebellar granule cells were isolated from +/+ and wv/wv mice. A, caspase-9, -8, and -3 are activated in +/+ and wv/wv cerebellar granule cells. Cells were fixed and immunostained for active caspase-9, -8, and -3 using antibodies specific for these proteins (red). 4',6-Diamidino-2-phenylindole staining was used to identify cell nuclei (blue). Original magnification, ×40. B, time course of caspase-9, -8, and -3 activities. Cytosolic protein extracts were from +/+ and wv/wv cerebellar granule cells grown in the absence or presence of 25 µM caspase-9 inhibitor, 25 µM caspase-8 inhibitor, and 25 µM caspase-3 inhibitor as described under "Experimental Procedures" (n = 4). *, p < 0.01; **, p < 0.001, significantly different from +/+. #, p < 0.01, significantly different from wv/wv.

To assess temporal activation of the individual caspases, we examined the activities of each using specific fluorometric caspase substrates. Wild-type cerebellar granule cells exhibited minimal activity of caspase-9, -3, and -8, whereas weaver cerebellar granule cells exhibited a significant 2-6-fold increase in levels of activated caspase-9, -3, and -8 at 18, 24, and 36 h in vitro, respectively (Fig. 1B). A selective caspase-9 inhibitor, Z-LEHD-FMK, significantly attenuated the increases in caspase-9, -3, and -8 activities, whereas neither the caspase-8 inhibitor (Z-IETD-FMK) nor the caspase-3 inhibitor (Z-DEVD-FMK) inhibited caspase-9 activity (Fig. 1B). These data corroborate our immunocytochemical data demonstrating the activation of these caspases in the weaver mouse and furthermore indicate that caspase-9 is activated upstream of both caspase-3 and -8.

Rescue of Weaver Cerebellar Granule Cells by Caspase Inhibition-- Granule neurons purified from P5-7 cerebella were cultured, and cell viability was measured by the MTT assay. As shown in Fig. 2A, there was a 25-50% greater incidence of death among wv/wv cells compared with +/+ neurons at 2 and 3 days in vitro. Granule neurons isolated from wv/wv cerebella were cultured in the presence of 20 µM MK-801, 20 µM verapamil, and 100 µM QX-314. Our data corroborate earlier findings (28) demonstrating that these cationic channel blockers markedly enhanced wv/wv granule cell viability (Fig. 2A), supporting the hypothesis that the mutant channel is nonselective, fluxing Na+. Our data show that wv/wv granule cell viability was equally protected by either a general or a caspase-9-specific caspase inhibitor. This suggests that caspase-9 activation is involved in the granule cell death associated with the wv/wv mutation (Fig. 2A).


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 2.   Rescue of weaver granule cells. A, cell viability in cerebellar granule cells in vitro as measured by MTT assay in +/+, wv/wv cells grown in the absence or presence of 20 µM MK-801, 20 µM verapamil, 100 µM QX-314, wv/wv cells expressing p35, or wv/wv cells grown in the presence of 25 µM caspase-9 inhibitor, n = 4. *, p < 0.001, significantly different from +/+. #, p < 0.01, significantly different from wv/wv. B, time course of caspase-9, caspase-3, and caspase-8 activities in presence of either cationic channel blockers or p35 (n = 4). *, p < 0.01; **, p < 0.001, significantly different from +/+. #, p < 0.01, significantly different from wv/wv.

Baculoviral p35 is a general caspase inhibitory protein similar to CrmA that acts to suppress host defense mechanisms that otherwise would eliminate virus-infected bacteria by apoptosis (29, 30). p35 is known to bind and to inhibit multiple vertebrate (26) and invertebrate caspases (31). It has been shown to protect against apoptosis induced by a variety of stimuli in a variety of different model systems (32). To assess the effect of the presence of GIRK2wv on caspase activation levels, time courses of activation of caspase-9, -3, and -8 in wv/wv cells in the absence or presence of p35 expression via crossing weaver mice with a transgenic mouse model previously generated in our laboratory (26) or pharmacological cationic channel blockers were performed. As shown in Fig. 2B, the intracellular activity levels of caspase-9, -3, and -8 were significantly increased in wv/wv granule neurons up to 48 h in vitro as compared with +/+ neurons. p35 expression had a profound effect on caspase activities, resulting in a significant decrease in caspase activation in granule cells from wv/wv with p35 mice (Fig. 2B). Significantly, the channel blockers MK-801, verapamil, and QX-314 largely prevented caspase-9, -3, and -8 activation in wv/wv granule neurons (Fig. 2B).

Developmental differentiation of cerebellar granule neurons can be monitored via the transient expression of TAG-1, a glycoprotein localized in the plasma membrane whose expression in cerebellar granule cells is restricted to the period of axonal elongation during the first two postnatal weeks in mice (28, 33). To test whether rescued wv/wv granule cells are able to proceed with differentiation, cultured cells were assayed for TAG-1, which is expressed by postmitotic +/+ granule cells during the period of axonogenesis (34) but not by weaver granule cells, which normally fail to differentiate (28). Surviving untreated weaver granule cells were TAG-1-negative as expected but did express the antigen if treated with the cationic channel inhibitor QX-314 as previously shown (28). As illustrated in Fig. 3, wv/wv, p35 granule cells also express TAG-1, demonstrating that caspase inhibition allows wv/wv granule cell differentiation to proceed through axonogenesis at least in vitro.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Axonal glycoprotein TAG-1 expression in cerebellar granule cells in vitro. Cerebellar granule cells were purified from P5 mice and cultured for 2 days before immunocytochemistry was performed to assess presence of TAG-1 expression (red). Nuclei were identified by counterstaining with 4',6-diamidino-2-phenylindole (blue). A, +/+. B, wv/wv. C, wv/wv with p35. D, wv/wv cells grown in the presence of 100 µM QX-314. Original magnification, ×40.

Apoptosis during Postnatal Cerebellar Development in Vivo Rescued by Caspase Inhibition-- To assess whether p35 expression attenuates apoptosis during cerebellar development in vivo, we used in situ end labeling to identify apoptotic cells (Fig. 4, A and B). The morphological and spatial characteristics of cell death were examined in the cerebella of P7 and P21 +/+ mice and wv/wv mice in the presence or absence of p35 expression. As previously shown (18), in situ end-labeling reactions carried out on sagittal sections from the vermis demonstrated substantial levels of apoptotic cell death in the cerebella of P7 wv/wv mice (Fig. 4A). TUNEL-labeled cells detected in the P7 cerebella were mostly found along the inner margin of the external germinal layer (EGL), where postmitotic, premigratory granule cells are positioned in +/+ mice at these ages, but a few were located in the internal granular layer (IGL). The numbers of TUNEL-labeled cells in the EGL appeared to be greatly reduced in wv/wv mice expressing p35. Few apoptotic cells were present in the EGL of the +/+ mice either in the absence or presence of p35 (Fig. 4A). Again, as previously demonstrated (18), by P21 the weaver cerebellum was found to display significant EGL cell loss with continued presence of TUNEL-labeled cells in the few remaining cells present and little normal migration into the IGL (Fig. 4B). In contrast, wv/wv mice expressing the p35 transgene appeared to display a decrease in TUNEL-labeled EGL cells compared with weaver alone as well as an increase in the number of cells in the IGL.


View larger version (102K):
[in this window]
[in a new window]
 
Fig. 4.   Morphological apoptotic cell death in developing +/+ and wv/wv cerebella in vivo in the absence or presence of p35 expression. Shown are photomicrographs of TUNEL cells (TUNEL cells are shown in red and indicated by white arrowheads in the +/+ panel) in sagittal sections from cerebella of P7 (A) and P21 (B) mice. Original magnification, ×20. The sections were counterstained with hematoxylin (purple). C, TUNEL cell counts performed in sagittal sections from wv/wv mice without or with p35 cerebella at P7 and P21 (n = 3). *, p < 0.01, significantly different from wv/wv. D, the number of granule cells in EGL of P7 cerebella (n = 3). *, p < 0.001, significantly different from +/+. #, p < 0.05, significantly different from wv/wv. E, the number of granule cells of P21 cerebella (n = 3). #, p < 0.01, significantly different from wv/wv.

To more carefully assess cellular apoptosis in the cerebellum in the absence or presence of p35 expression, the numbers of TUNEL cells in the EGL near the vermis were quantitated in wv/wv mice in the absence or presence of p35 expression. A significant reduction in the numbers of TUNEL cells in the EGL of wv/wv mice expressing p35 compared with control wv/wv mice at both P7 and P21 was observed (Fig. 4C). Furthermore, there was a significant increase in the total number of EGL granule cells in P7 wv/wv mice in the presence versus absence of p35 expression, whereas no significant difference in EGL granule cell numbers was observed between P7 +/+ mice in the absence or presence of p35 expression (Fig. 4D). No significant difference in IGL or total granule cell numbers was noted between +/+ mice in the absence or presence of the transgene by P21 (data not shown). However, as shown in Fig. 4E, an increase in the total number of granule cells including IGL was observed in P21 wv/wv mice expressing p35 compared with wv/wv mice.

To assess caspase activation in vivo in wv/wv mice with or without p35 expression, we used immunohistochemical localization with a cleaved caspase-3-specific antibody (Fig. 5). Whereas intense staining for cleaved caspase-3 was observed throughout the cerebellar EGL of wv/wv mice not expressing p35 (Fig. 5A), in the cerebellum from P7 wv/wv animals expressing the transgene, markedly fewer cleaved caspase-3-positive cells were found compared with wv/wv only littermates (Fig. 5B). Wild-type cerebella showed negligible caspase-3 immunostaining (data not shown).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Caspase inhibitor attenuates caspase-3 activation in vivo. Photomicrographs of cleaved caspase-3 immunolabeled cells (red) in sagittal sections from EGL of cerebella from P7 wv/wv mice in the absence (A) or presence (B) of p35 expression staining seen throughout EGL is much reduced by p35. Individual cells and clusters are shown (arrowheads). Scale bar, 100 µm.

Behavioral Deficits in Weaver Mice Attenuated by Caspase Inhibition-- The weaver behavioral phenotype is characterized by gait instability, outward splaying of hind limbs, tremor, curled posture, and severe ataxia (35). Presumably, the massive loss of granule cells accounts for at least some of the weaver's motor deficiencies. In the present experiments, the performance of P21 +/+, wv/+, and wv/wv mice both expressing p35 and not expressing p35 was compared on a battery of behavioral tests in an open field environment. The tests included spontaneous locomotion, mean velocity, rest time, and climbing ability. We observed no significant difference in these four parameters between +/+ and wv/+ mice, whether or not they expressed p35, consistent with past reports. In contrast, wv/wv mice had decreased locomotor behavior (i.e. movement was slower, and they moved shorter distances per move) and increased rest time compared with +/+ or wv/+ over a 10-min trial period. During the rest periods, defined as lack of detectable activity by the apparatus for a period of 2 s or longer, we observed that wv/wv mice remained fairly stationary. In contrast, the +/+ mice were engaged in grooming behavior during the rest period. In addition, the wv/wv mice were ~10 times slower to crawl onto a platform from a hole 23 mm deep × 22 mm in diameter at the bottom of the apparatus. The behavioral deficits in the wv/wv were partially rescued in the presence of p35 expression (Fig. 6). These data point to an improvement in coordination in the weaver mice that express the p35 transgene.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Behavioral differences in weaver mice with or without p35 expression. A, average distance per move. B, mean velocity. C, rest time. D, total time spent in hole. All experiments were performed during a 10-min trial period after 15 min of habituation to the apparatus. Rest times were considered to be any cessation in detectable activity for a period of 2 s or longer. For hole climbing experiments, animals were placed in 23-cm holes of 22-mm diameter, and the time to climb out was assessed. Sample sizes were 5 (+/+, p35 -/-), 9 (+/+, p35 ±), 8 (+/+, p35 +/+), 7 (wv/+, p35 -/-), 16 (wv/+, p35 ±), 13 (wv/+, p35 +/+), 4 (wv/wv, p35 -/-), 10 (wv/wv, p35 +/-), and 9 (wv/wv, p35 +/+). *, p < 0.05; **, p < 0.01, significantly different from wild-type; #, p < 0.05; ##, p < 0.01, significantly different from p35 -/-.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell death in the weaver mouse has up until now been primarily described morphologically (3, 4, 18) with limited biochemical evidence suggesting by what mechanism this occurs (36, 37). Although a few studies have implicated apoptosis in weaver cerebellar granule cell death (18, 36), the exact cause of apoptotic cell death remains unknown. Apoptosis has been shown to occur by both caspase-dependent and -independent means. We show here that the mutation that leads to the weaver phenotype, Girk2wv, elicits apoptosis in granule cells by caspase activation. Furthermore, results from our pharmacological and immunocytochemical experiments establish that caspase-9 is the apical upstream caspase involved in cerebellar granule cell death in the weaver mouse. Caspase-9 is normally involved in propagating intracellular apoptotic stimuli. Caspase-9 can in turn cleave and activate downstream executioner caspases such as caspase-3. This leads to cleavage of additional cellular substrates, resulting in morphological changes associated with apoptosis including DNA fragmentation and cytoskeletal disruption (38, 39). Recent evidence from cell-free and in vitro expression systems have suggested that in addition to being a final effector in neuronal apoptosis, caspase-3 is also capable of eliciting cleavage and activation of the initiator caspase, caspase-8 (40, 41). Although caspase-8 activation is generally thought to occur upstream of caspase-9, we have recently demonstrated that caspase-8 activation in dopaminergic neurons in the MPTP mouse model of Parkinson's disease occurs downstream of activation of both caspase-9 and caspase-3 (42). Neuronal cell death in the weaver's cerebellum may involve a similar pathway of caspase activation. This is to our knowledge the first identification of a molecular cell death pathway acting downstream of the altered ion channel function responsible for cell loss in the weaver mutant.

Intriguingly, caspase-3 was found in our studies to be expressed throughout the EGL in P7 weaver mice including in the external-most subdivision where the proliferating granule cells reside. The GIRK2 channel protein has also been found to be expressed in mitotic cells of the EGL (28, 43-45). In contrast, TUNEL staining (a marker of DNA fragmentation, a late stage in the apoptotic process) is found primarily in the postmitotic cells at the internal edge of the EGL (Fig. 4) (18). Taken together, these data suggest that caspase-induced apoptosis triggered by the GIRK2 mutation is initiated during the mitotic phase in cerebellar granule neurons, although cell death becomes morphologically evident only later at the time of postmitotic differentiation.

These studies also show that neuronal expression of the baculoviral protein p35 significantly attenuates caspase activation both in vitro and in vivo, resulting in a reduction in numbers of apoptotic cerebellar granule cells in wv/wv mice and an increase in IGL cell numbers (Fig. 4), although not all granule cells containing the GIRK2 mutation undergo cell death but primarily those at the vermis (13, 19). This suggests decreased apoptosis and increased migration of cells from the EGL to the IGL in wv/wv mice in the presence of the p35 transgene. In previous studies of this line of p35 transgene, we observed the highest level of expression of the transgene in the cerebellum. In addition, neuronal expression of p35 in these animals was found to significantly lower caspase activation induced by either staurosporine or lowered extracellular K+ levels in primary cerebellar granule cells cultured in vitro (26).

Our present data demonstrate that caspase inhibition via p35 allows weaver cerebellar granule cell differentiation to proceed in vitro as exemplified by their expression of the late neuronal differentiation marker TAG-1. Weaver cerebellar granule cells without p35 fail to extend axonal processes and to express TAG-1 (28, 46). This suggests that caspase inhibition and subsequent attenuation of granule cell death allows some cells to differentiate beyond the stage of migration and axonogenesis, which could explain the observed improvement in coordination in these animals in vivo. These data are further corroborated by in vivo increases in the number of cells in the P21 IGL of the p35-expressing weaver mice, suggesting that the presence of the transgene results in a delay in apoptotic cell death. Delayed cell death could allow some cells to undergo normal migration from the EGL to the IGL and to functionally differentiate. The presence of TUNEL cells in the IGL further suggests that apoptosis may be delayed in these cells. Whereas p35 expression does not fully reverse cerebellar granule cell loss in the weaver, the rescue is sufficient to allow diminished cell loss and a partial attenuation of behavioral effects in the presence of the transgene.

The results of this study are consistent with the view that Na+ influx is responsible for subsequent caspase activation and apoptotic cell death in weaver cerebellar granule cells. Previous electrophysiological experiments using heterologous systems have suggested that GIRK2wv results in Na+ influx through a nonselective channel (28, 43, 47, 48). Electrophysiological studies of the weaver's granule neurons have proven more controversial. Some groups have reported that the mutated channel appears to be nonselective, leading to increased Na+ permeability (28, 43, 47, 48), whereas others have reported that the mutation results in loss in channel function (49, 50). Our in vitro data agree with earlier reports that neurons can be rescued from apoptotic cell death by the addition of cationic channel blockers (e.g. MK-801, verapamil, and QX-314). We found here that these same channel blockers also prevent caspase-9, -8, and -3 activation. This suggests that cationic influx is required for caspase activation, triggering this otherwise irreversible program of cell death (Fig. 2).

In conclusion, we have demonstrated that the mutant channel in granule cells results in subsequent caspase activation in vitro and in vivo. The activation of caspases is initiated prior to differentiation in mitotic cells in the EGL. Furthermore, based on immunocytochemistry and enzymatic assays, caspase-9 is the apical caspase involved in the subsequent neuronal cell death process, which also involves caspase-3 and -8 (Fig. 7). Caspase inhibition by p35 decreases caspase activation and allows neuronal differentiation to proceed in the weaver's granule cells, resulting in an attenuation in cerebellar granule apoptosis both in vitro and in vivo and at least some degree of normal migration and differentiation in vivo. Cerebellar granule cell viability in association with an improvement in weaver behavior has been previously reported by another group (19). Interestingly, in this case granule cells were reversed when NR1 N-methyl-D-aspartate subunits were knocked out in weaver NR1 double mutants. The differences in behavioral deficits were described, but quantitative data were not presented. We also found that the partial block or delay in cell death has functional consequences. Homozygous weaver mice that also carried p35 were far better coordinated and less ataxic that homozygous weavers without p35. p35 reversed the motor deficits seen in homozygous weavers in all four tests of motor behavior administered. This was particularly striking in the hole climbing task. Weaver mice without p35 were dramatically impaired in terms of their ability to climb out of a 23-cm hole. However, in the presence of the p35 transgene, this was completely reversed to wild-type levels.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Proposed mechanism of weaver cerebellar granule apoptotic cell death. The Girk2 channel mutation results in Na+ and/or Ca2+ influx. The increase in intracellular cation levels leads to the activation of caspase-9 and the subsequent activation of procaspase-3 and -8, resulting in neuronal cell apoptosis.

Understanding the molecular events underlying neuronal cell loss in the weaver's mouse and how to reverse them may not only aid us in understanding this specific process but also may lend insight into treatment of related human disorders in which neurodegeneration plays a major role.

    ACKNOWLEDGEMENT

We thank Dr. Joan C. Schein for helpful suggestions on the PCR.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants AG12141, NS21461, and AG51980 (to J. K. A.) and NS20181 (to S. K. R.-T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Buck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945. Tel.: 415-209-2070; Fax: 415-209-2231; E-mail: jandersen@buckinstitute.org.

Published, JBC Papers in Press, September 6, 2002, DOI 10.1074/jbc.M207407200

    ABBREVIATIONS

The abbreviations used are: MK-801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeled; EGL, external germinal layer; IGL, internal granular layer; Z-, benzyloxycarbonyl-; P5, P7, and P21, postnatal day 5, 7, and 21, respectively; FMK, fluoromethylketone; AFC, 7-amino-4-trifluoromethyl coumarin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Caviness, V. S., Jr., and Rakic, P. (1978) Annu. Rev. Neurosci. 1, 297-326[CrossRef][Medline] [Order article via Infotrieve]
2. Rezai, Z., and Yoon, C. H. (1972) Dev. Biol. 29, 17-26[CrossRef][Medline] [Order article via Infotrieve]
3. Rakic, P., and Sidman, R. L. (1973) J. Comp. Neurol. 152, 103-132[CrossRef][Medline] [Order article via Infotrieve]
4. Rakic, P., and Sidman, R. L. (1973) J. Comp. Neurol. 152, 133-161[CrossRef][Medline] [Order article via Infotrieve]
5. Schmidt, M. J., Sawyer, B. D., Perry, K. W., Fuller, R. W., Foreman, M. M., and Ghetti, B. (1982) J. Neurosci. 2, 376-380[Abstract]
6. Roffler-Tarlov, S., and Graybiel, A. M. (1984) Nature 307, 62-66[CrossRef][Medline] [Order article via Infotrieve]
7. Triarhou, L. C., Norton, J., and Ghetti, B. (1988) Exp. Brain Res. 70, 256-265[Medline] [Order article via Infotrieve]
8. Graybiel, A. M., Ohta, K., and Roffler-Tarlov, S. (1990) J. Neurosci. 10, 720-733[Abstract]
9. Roffler-Tarlov, S., Martin, B., Graybiel, A. M., and Kauer, J. S. (1996) J. Neurosci. 16, 1819-1826[Abstract/Free Full Text]
10. Blatt, G. J., and Eisenman, L. M. (1985) J. Comp. Neurol. 232, 117-128[CrossRef][Medline] [Order article via Infotrieve]
11. Herrup, K., and Trenkner, E. (1987) Neuroscience 23, 871-885[CrossRef][Medline] [Order article via Infotrieve]
12. Smeyne, R. J., and Goldowitz, D. (1990) Brain Res. Dev. Brain Res. 52, 211-218[Medline] [Order article via Infotrieve]
13. Maricich, S. M., Soha, J., Trenkner, E., and Herrup, K. (1997) J. Neurosci. 17, 3675-3683[Abstract/Free Full Text]
14. Patil, N., Cox, D. R., Bhat, D., Faham, M., Myers, R. M., and Peterson, A. S. (1995) Nat. Genet. 11, 126-129[CrossRef][Medline] [Order article via Infotrieve]
15. Clapham, D. E. (1994) Annu. Rev. Neurosci. 17, 441-464[CrossRef][Medline] [Order article via Infotrieve]
16. Ehrengruber, M. U., Doupnik, C. A., Xu, Y., Garvey, J., Jasek, M. C., Lester, H. A., and Davidson, N. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7070-7075[Abstract/Free Full Text]
17. Smeyne, R. J., and Goldowitz, D. (1989) J. Neurosci. 9, 1608-1620[Abstract]
18. Harrison, S. M., and Roffler-Tarlov, S. K. (1998) Dev. Biol. 195, 174-186[CrossRef][Medline] [Order article via Infotrieve]
19. Jensen, P., Surmeier, D. J., and Goldowitz, D. (1999) J. Neurosci. 19, 7991-7998[Abstract/Free Full Text]
20. Salvesen, G. S., and Dixit, V. M. (1997) Cell 91, 443-446[CrossRef][Medline] [Order article via Infotrieve]
21. Cryns, V., and Yuan, J. (1998) Genes Dev. 12, 1551-1570[Free Full Text]
22. Henderson, C. E. (1996) Neuron 17, 579-585[CrossRef][Medline] [Order article via Infotrieve]
23. Kuida, K., Haydar, T. F., Kuan, C. Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S., Rakic, P., and Flavell, R. A. (1998) Cell 94, 325-337[CrossRef][Medline] [Order article via Infotrieve]
24. Yakovlev, A. G., Knoblach, S. M., Fan, L., Fox, G. B., Goodnight, R., and Faden, A. I. (1997) J. Neurosci. 17, 7415-7424[Abstract/Free Full Text]
25. Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., and Moskowitz, M. A. (1998) J. Neurosci. 18, 3659-3668[Abstract/Free Full Text]
26. Viswanath, V., Wu, Z., Fonck, C., Wei, Q., Boonplueang, R., and Andersen, J. K. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 2270-2275[Abstract/Free Full Text]
27. Hatten, M. E. (1985) J. Cell Biol. 100, 384-396[Abstract/Free Full Text]
28. Kofuji, P., Hofer, M., Millen, K. J., Millonig, J. H., Davidson, N., Lester, H. A., and Hatten, M. E. (1996) Neuron 16, 941-952[CrossRef][Medline] [Order article via Infotrieve]
29. Clem, R. J., Fechheimer, M., and Miller, L. K. (1991) Science 254, 1388-1390[Abstract/Free Full Text]
30. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., and Pickup, D. J. (1992) Cell 69, 597-604[CrossRef][Medline] [Order article via Infotrieve]
31. Sugimoto, A., Friesen, P. D., and Rothman, J. H. (1994) EMBO J. 13, 2023-2028[Medline] [Order article via Infotrieve]
32. Miller, L. K. (1999) Trends Cell Biol. 9, 323-328[CrossRef][Medline] [Order article via Infotrieve]
33. Bailly, Y., Kyriakopoulou, K., Delhaye-Bouchaud, N., Mariani, J., and Karagogeos, D. (1996) J. Comp. Neurol. 369, 150-161[CrossRef][Medline] [Order article via Infotrieve]
34. Yamamoto, M., Hassinger, L., and Crandall, J. E. (1990) J. Neurocytol. 19, 619-627[CrossRef][Medline] [Order article via Infotrieve]
35. Sidman, R. L., Green, M. C., and Appel, S. H. (1965) Catalog of the Neurological Mutants of the Mouse , pp. 66-67, Harvard University Press, Cambridge, MA
36. Wullner, U., Weller, M., Schulz, J. B., Krajewski, S., Reed, J. C., and Klockgether, T. (1998) Acta Neuropathol. 96, 233-238[CrossRef][Medline] [Order article via Infotrieve]
37. Migheli, A., Piva, R., Casolino, S., Atzori, C., Dlouhy, S. R., and Ghetti, B. (1999) Am. J. Pathol. 155, 365-373[Abstract/Free Full Text]
38. Nunez, G., Benedict, M. A., Hu, Y., and Inohara, N. (1998) Oncogene 17, 3237-3245[CrossRef][Medline] [Order article via Infotrieve]
39. Stennicke, H. R., and Salvesen, G. S. (2000) Biochim. Biophys. Acta 1477, 299-306[CrossRef][Medline] [Order article via Infotrieve]
40. Wolf, B. B, and Green, D. R. (1999) J. Biol. Chem. 274, 20049-20052[Free Full Text]
41. Tang, D., Lahti, J. M., and Kidd, V. J. (2000) J. Biol. Chem. 275, 9303-9307[Abstract/Free Full Text]
42. Viswanath, V., Wu, Y., Boonplueang, R., Chen, S., Stevenson, F. F., Yantiri, F., Yang, L., Beal, M. F., and Andersen, J. K. (2001) J. Neurosci. 21, 9519-9528[Abstract/Free Full Text]
43. Slesinger, P. A., Patil, N., Liao, Y. J., Jan, Y. N., Jan, L. Y., and Cox, D. R. (1996) Neuron 16, 321-331[CrossRef][Medline] [Order article via Infotrieve]
44. Lauritzen, I., De, Weille, J., Adelbrecht, C., Lesage, F., Murer, G., Raisman-Vozari, R., and Lazdunski, M. (1997) Brain Res. 753, 8-17[CrossRef][Medline] [Order article via Infotrieve]
45. Schein, J. C., Hunter, D. D., and Roffler-Tarlov, S. (1998) Dev. Biol. 204, 432-450[CrossRef][Medline] [Order article via Infotrieve]
46. Gao, W. Q., Liu, X. L., and Hatten, M. E. (1992) Cell 68, 841-854[CrossRef][Medline] [Order article via Infotrieve]
47. Navarro, B., Kennedy, M. E., Velimirovic, B., Bhat, D., Peterson, A. S., and Clapham, D. E. (1996) Science 272, 1950-1953[Abstract]
48. Silverman, S. K., Kofuji, P., Dougherty, D. A., Davidson, N., and Lester, H. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15429-15434[Abstract/Free Full Text]
49. Surmeier, D. J., Mermelstein, P. G., and Goldowitz, D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11191-11195[Abstract/Free Full Text]
50. Rossi, P., De, Filippi, G., Armano, S., Taglietti, V., and D'Angelo, E. (1998) J. Neurosci. 18, 3537-3547[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. Peng, L. Peng, F. F. Stevenson, S. R. Doctrow, and J. K. Andersen
Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration
J. Neurosci., June 27, 2007; 27(26): 6914 - 6922.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Peng, L. Xie, F. F. Stevenson, S. Melov, D. A. Di Monte, and J. K. Andersen
Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration.
J. Neurosci., November 8, 2006; 26(45): 11644 - 11651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Peng, F. F. Stevenson, S. R. Doctrow, and J. K. Andersen
Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra: IMPLICATIONS FOR PARKINSON DISEASE
J. Biol. Chem., August 12, 2005; 280(32): 29194 - 29198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Peng, X. O. Mao, F. F. Stevenson, M. Hsu, and J. K. Andersen
The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway
J. Biol. Chem., July 30, 2004; 279(31): 32626 - 32632.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/46/44285    most recent
M207407200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, J.
Right arrow Articles by Andersen, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, J.
Right arrow Articles by Andersen, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement